Effects of Caffeine on Upper Extremity Performance

Sponsor
Cyprus International University (Other)
Overall Status
Completed
CT.gov ID
NCT05916352
Collaborator
(none)
50
1
2
11.1
4.5

Study Details

Study Description

Brief Summary

It was aimed to apply caffeine supplement to elite basketball players and to investigate the effects of this supplement on upper extremity performance, lactic acid level and fatigue. The investigators also aimed to investigate the effects of blood lactate level on performance and fatigue.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Caffeine Supplement
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The research is a double-blind randomized controlled comparative cross-sectional study.The research is a double-blind randomized controlled comparative cross-sectional study.
Masking:
Double (Participant, Investigator)
Primary Purpose:
Diagnostic
Official Title:
The Effect of Caffeine Supplementation on Blood Lactate Level, Performance and Post-Training Fatigue in Elite Basketball Players
Actual Study Start Date :
Jul 4, 2022
Actual Primary Completion Date :
Oct 14, 2022
Actual Study Completion Date :
Jun 6, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Caffeine Group

5 mg/kg caffein supplement will be given

Dietary Supplement: Caffeine Supplement
Caffeine tablet

Placebo Comparator: Placebo Group

Placebo will be given

Dietary Supplement: Caffeine Supplement
Caffeine tablet

Outcome Measures

Primary Outcome Measures

  1. Blood Lactate Level [2 hours]

    Lactic acid level in the blood

Secondary Outcome Measures

  1. Reaction Time [5 minutes]

    Arm movement speed

  2. Anaerobic Power [5 minutes]

    Upper extremity explosive force will be measured with medicine ball

  3. Muscular Endurance [5 minutes]

    Endurance time will be measured using a 1 kg Dynamometer.

  4. Fatigue [1 minute]

    Subjective fatigue will be measured using the Visual Analog Scale.

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 44 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Elite basketball players aged 19-44

  • Individuals with caffeine consumption below 2 mg per kg per day

Exclusion Criteria:
  • Individuals with systemic disease affecting the musculoskeletal system

  • Individuals using supplements containing caffeine

  • Individuals with any diagnosed neurological or orthopedic disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cyprus International University Mersin Turkey

Sponsors and Collaborators

  • Cyprus International University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Prof. Dr. Sıddıka Fatma Uygur, Academic Professor, Cyprus International University
ClinicalTrials.gov Identifier:
NCT05916352
Other Study ID Numbers:
  • -020-7249
First Posted:
Jun 23, 2023
Last Update Posted:
Jun 23, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Prof. Dr. Sıddıka Fatma Uygur, Academic Professor, Cyprus International University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 23, 2023